Unknown

Dataset Information

0

Antigen and checkpoint receptor engagement recalibrates T cell receptor signal strength.


ABSTRACT: How T cell receptor (TCR) signal strength modulates T cell function and to what extent this is modified by immune checkpoint blockade (ICB) are key questions in immunology. Using Nr4a3-Tocky mice, we characterized early quantitative and qualitative changes that occur in CD4+ T cells in relation to TCR signaling strength. We captured how dose- and time-dependent programming of distinct co-inhibitory receptors rapidly recalibrates T cell activation thresholds and visualized the immediate effects of ICB on T cell re-activation. Our findings reveal that anti-PD1 immunotherapy leads to an increased TCR signal strength. We defined a strong TCR signal metric of five genes upregulated by anti-PD1 in T cells (TCR.strong), which was superior to a canonical T cell activation gene signature in stratifying melanoma patient outcomes to anti-PD1 therapy. Our study therefore reveals how analysis of TCR signal strength-and its manipulation-can provide powerful metrics for monitoring outcomes to immunotherapy.

SUBMITTER: Elliot TAE 

PROVIDER: S-EPMC8585507 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2020-09-30 | GSE137406 | GEO
| S-EPMC4551349 | biostudies-literature
| S-EPMC2626685 | biostudies-literature
| PRJNA565386 | ENA
| S-EPMC6442064 | biostudies-literature
2016-03-29 | E-GEOD-71637 | biostudies-arrayexpress
2021-07-30 | GSE165817 | GEO
| S-EPMC4593123 | biostudies-literature
| S-EPMC4136588 | biostudies-literature
2016-03-29 | GSE71637 | GEO